Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
• Retinal navigation
• SRT and DME
• Diagnostics
• Glaucoma
• Appointment
• AAO attendance
Survey

DO you primarily perform LASIK or PRK procedures?
Novartis

LASIK

64%

PRK

21%

Neither

14%


You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Neil Hanley, sales manager.
 
NOVEMBER 11, 2009
Retinal navigation system gains approval
The NAVILAS laser system, as reported on in the OTE Digest back in May this year (see What is Retinal Navigation?) has been given FDA approval. The new navigated laser system incorporates advanced imaging with retinal laser therapy in a planned and controlled way using image registration in one device with integrated workflow to improve the safety, accuracy, speed, comfort and transparency of retina laser photocoagulation which is the current standard in the treatment of many retinal disorders including Diabetic Retinopathy and Diabetic Macular Edema (DME).More...
Lumenis initiates clinical study into SRT efficacy in DME
Lumenis is to undertake a clinical study into the efficacy of selective retina therapy (SRT) in diabetic macular oedema (DME). It will be conducted by Dr Anat Loewenstein, an associate professor of ophthalmology & the vice-dean of the Sackler Faculty of Medicine at the Tel aviv University in Israel and include 102 patients. More...
New generation of diagnostic ultrasound system unveiled
“In an era of high-tech optical coherence tomography scanning and digital imaging, ultrasound is the only means to obtain a crucial view of the posterior segment when there is a dense cataract or vitreous hemorrhage in the eye,” More...
Laser system for treatment of glaucoma gets European patent approval
The IOPtiMate laser-based system, from the Bio-Light Group, used for the non-invasive filtration treatment of glaucoma has received European Patent Office approval.
The technology is a CO2 laser-based system which enables the filtration procedure for the alleviation of Intra Ocular Pressure. More...
Santen CEO joins Glaucoma Research Foundation
Adrienne Graves, CEO of Santen Inc., has been appointed to the Glaucoma Research Foundation’s board of directors. More...
6,000 international doctors made the trip to AAO
Preliminary figures for attendance at the largest ophthalmic educational meeting in the world were approximately 25,000, a 17 percent increase over 2008. More...

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.